封面
市场调查报告书
商品编码
1907822

全球经皮冠状动脉介入治疗(PTCA)球囊导管市场 - 市场规模(按细分市场划分)、占有率、法规、报销、介入治疗及预测(至 2036 年)

PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本报告探讨并分析了全球 PTCA 球囊导管市场,提供了有关区域市场规模、关键趋势、创新产品和技术以及竞争格局的资讯。

市场模型的主要组成如下:

已上市的 PTCA 球囊导管及不断变化的竞争格局

  • 关键产业趋势探讨
  • PTCA 球囊导管市场各细分市场的年度收入和市场展望(2015-2036 年)
  • 各细分市场的总介入治疗量、单位销售量、平均售价及市场价值的详细数据

全球、区域与国家各市场的探讨层级

  • 按地区和国家细分的定性市场资讯讨论
  • PTCA球囊导管市场SWOT分析
  • PTCA球囊导管市场竞争动态与趋势讨论

全面的视角,包括对医疗保健系统的概述,有助于理解市场。此外,市场参与部分提供有关报销政策和监管环境的信息,从而可以更深入地了解市场动态。

  • 各国医疗保健系统概述
  • 报销政策
  • 医疗科技监管环境

目标公司

  • Shockwave Medical Inc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • B. Braun Melsungen AG
  • Biotronik SE & Co KG
  • Terumo Corp
  • Koninklijke Philips NV
  • Microport Scientific Corp
  • Lepu Medical Technology (Beijing) Co Ltd
  • OrbusNeich
  • Meril Life Sciences Pvt Ltd
  • Teleflex Inc
  • 其他
简介目录
Product Code: GDME676MM

PTCA Balloon Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Percutaneous Transluminal Coronary Angioplasty (PTCA) is a intervention that helps restore blood flow to the blocked coronary artery without the requirement of open-heart surgery. In this intervention, a balloon at the end of a catheter is expanded to open the blocked coronary artery by compressing the plaque. PTCA has become the basic interventional modality because of its minimally invasive nature.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed PTCA Balloon Catheters and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total PTCA Balloon Catheters market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for PTCA Balloon Catheters market.
  • Competitive dynamics insights and trends provided for PTCA Balloon Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Shockwave Medical Inc, Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, B. Braun Melsungen AG, Biotronik SE & Co KG, Terumo Corp, Koninklijke Philips NV, Microport Scientific Corp, Lepu Medical Technology (Beijing) Co Ltd, OrbusNeich, Meril Life Sciences Pvt Ltd, Teleflex Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the PTCA Balloon Catheters marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving PTCA Balloon Catheters market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the PTCA Balloon Catheters market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific PTCA Balloon Catheters market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.